New research about breast cancer treatment from the Perelman School of Medicine’s Justin Bekelman and Ezekiel Emanuel, also of the Whar
Health & Medicine
Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.
A new chemical-genetic therapy restores light responses to the retinas of blind mice and dogs and enables the mice to guide their behavior according to visual cues, setting the stage for clinical trial in humans.
By Madeleine Stone @themadstone
Quitting smoking sets off a series of changes in the brain that Penn Medicine researchers say may better identify smokers who will start smoking again—a prediction that goes above and beyond today’s clinical or behavioral tools for assessing relapse risk.
Mitesh Patel of the Perelman School of Medicine comments on boosting the frequency of physicians prescribing generic br